1 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Adenoid Cystic Carcinoma Metastatic: new trials by email Literature Review of Adenoid Cystic Carcinoma Metastatic trials Research Report on Adenoid Cystic Carcinoma Metastatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) Sacituzumab Tirumotecan - Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic | Phase 2 | Not yet recruiting | National Cancer Centre, Singapore | 68 | 2026-11-01 | 2026-07-15 |
| First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor JBI-778 - NSCLC Patients With EGFR Activating Mutation, Adenoid Cystic Carcinoma Metastatic | Phase 1 | Recruiting | Jubilant Therapeutics India Limited | 30 | 2024-08-26 | 2026-08-10 |
Carcinoma, Adenoid Cystic (1) · Neoplasm Metastasis (1) · Recurrence (1) · Thyroid Cancer, Papillary (1)
Adenocarcinoma (1) · Adenocarcinoma, Papillary (1) · Carcinoma (1) · Disease Attributes (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Thyroid Diseases (1)
Jubilant Therapeutics India Limited (1) · National Cancer Centre, Singapore (1)
India (1) · Japan (1) · Malaysia (1) · Singapore (1) · South Korea (1)